Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCESS: ACE-Inhibitors in Aortic Stenosis
NCT00252317Phase 4Unknown
- Sponsor
- Rigshospitalet
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of trandolapril in aortic stenosis (AS), sponsored by Rigshospitalet. Primary endpoint: Invasive measured haemodynamic parameters at 8 weeks. Status: unknown.
02
Drugs
trandolapril
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NCT00252317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252317.